nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—SLCO2B1—Estrone—prostate cancer	0.17	0.372	CbGbCtD
Niacin—SLCO2B1—Conjugated Estrogens—prostate cancer	0.111	0.243	CbGbCtD
Niacin—SLCO2B1—Estradiol—prostate cancer	0.0974	0.213	CbGbCtD
Niacin—CYP2D6—Bicalutamide—prostate cancer	0.0395	0.0866	CbGbCtD
Niacin—CYP2D6—Abiraterone—prostate cancer	0.0327	0.0718	CbGbCtD
Niacin—HCAR2—prostate gland—prostate cancer	0.00955	0.113	CbGeAlD
Niacin—QPRT—renal system—prostate cancer	0.00777	0.0918	CbGeAlD
Niacin—CYP2D6—Doxorubicin—prostate cancer	0.00605	0.0133	CbGbCtD
Niacin—NNMT—prostate gland—prostate cancer	0.00537	0.0635	CbGeAlD
Niacin—NNMT—seminal vesicle—prostate cancer	0.00454	0.0537	CbGeAlD
Niacin—HCAR2—testis—prostate cancer	0.00421	0.0497	CbGeAlD
Niacin—SLC16A3—prostate gland—prostate cancer	0.00367	0.0434	CbGeAlD
Niacin—NNMT—renal system—prostate cancer	0.00366	0.0433	CbGeAlD
Niacin—NNMT—urethra—prostate cancer	0.0036	0.0425	CbGeAlD
Niacin—HCAR2—lymph node—prostate cancer	0.00305	0.036	CbGeAlD
Niacin—NNMT—bone marrow—prostate cancer	0.00277	0.0327	CbGeAlD
Niacin—SLC16A3—epithelium—prostate cancer	0.0027	0.0319	CbGeAlD
Niacin—SLC16A3—renal system—prostate cancer	0.0025	0.0296	CbGeAlD
Niacin—SLC16A3—urethra—prostate cancer	0.00246	0.029	CbGeAlD
Niacin—NNMT—testis—prostate cancer	0.00237	0.028	CbGeAlD
Niacin—CYP2D6—urine—prostate cancer	0.00229	0.0271	CbGeAlD
Niacin—SLC16A1—prostate gland—prostate cancer	0.00223	0.0263	CbGeAlD
Niacin—SLCO2B1—prostate gland—prostate cancer	0.00192	0.0227	CbGeAlD
Niacin—SLC16A3—bone marrow—prostate cancer	0.00189	0.0223	CbGeAlD
Niacin—Metyrapone—CYP2A6—prostate cancer	0.00176	0.434	CrCbGaD
Niacin—NNMT—lymph node—prostate cancer	0.00172	0.0203	CbGeAlD
Niacin—SLC16A1—epithelium—prostate cancer	0.00164	0.0194	CbGeAlD
Niacin—SLC16A3—testis—prostate cancer	0.00162	0.0191	CbGeAlD
Niacin—SLC16A1—renal system—prostate cancer	0.00152	0.018	CbGeAlD
Niacin—SLCO2B1—renal system—prostate cancer	0.00131	0.0154	CbGeAlD
Niacin—SLC22A5—prostate gland—prostate cancer	0.00127	0.0151	CbGeAlD
Niacin—Metyrapone—CYP2E1—prostate cancer	0.00125	0.308	CrCbGaD
Niacin—SLC16A3—lymph node—prostate cancer	0.00117	0.0138	CbGeAlD
Niacin—SLC22A5—seminal vesicle—prostate cancer	0.00108	0.0127	CbGeAlD
Niacin—SLC16A1—testis—prostate cancer	0.000982	0.0116	CbGeAlD
Niacin—SLC22A5—renal system—prostate cancer	0.000868	0.0103	CbGeAlD
Niacin—SLC22A5—urethra—prostate cancer	0.000853	0.0101	CbGeAlD
Niacin—SLCO2B1—testis—prostate cancer	0.000845	0.00998	CbGeAlD
Niacin—Metyrapone—CYP3A4—prostate cancer	0.000785	0.194	CrCbGaD
Niacin—SLC16A1—lymph node—prostate cancer	0.000712	0.00841	CbGeAlD
Niacin—SLCO2B1—lymph node—prostate cancer	0.000612	0.00724	CbGeAlD
Niacin—SLC22A5—testis—prostate cancer	0.000561	0.00663	CbGeAlD
Niacin—CYP2D6—renal system—prostate cancer	0.00056	0.00662	CbGeAlD
Niacin—SLC22A5—lymph node—prostate cancer	0.000407	0.00481	CbGeAlD
Niacin—CYP2D6—testis—prostate cancer	0.000362	0.00428	CbGeAlD
Niacin—Salicylic acid—PTGS2—prostate cancer	0.000259	0.064	CrCbGaD
Niacin—Dry mouth—Docetaxel—prostate cancer	7.05e-05	0.000278	CcSEcCtD
Niacin—Sweating—Epirubicin—prostate cancer	7e-05	0.000276	CcSEcCtD
Niacin—Arthralgia—Capecitabine—prostate cancer	6.98e-05	0.000275	CcSEcCtD
Niacin—Myalgia—Capecitabine—prostate cancer	6.98e-05	0.000275	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	6.93e-05	0.000273	CcSEcCtD
Niacin—Oedema—Docetaxel—prostate cancer	6.91e-05	0.000272	CcSEcCtD
Niacin—Anaphylactic shock—Docetaxel—prostate cancer	6.91e-05	0.000272	CcSEcCtD
Niacin—Vision blurred—Prednisone—prostate cancer	6.88e-05	0.000271	CcSEcCtD
Niacin—Diarrhoea—Mitoxantrone—prostate cancer	6.84e-05	0.00027	CcSEcCtD
Niacin—Dry mouth—Capecitabine—prostate cancer	6.82e-05	0.000269	CcSEcCtD
Niacin—Vomiting—Estradiol—prostate cancer	6.82e-05	0.000269	CcSEcCtD
Niacin—Gastrointestinal pain—Etoposide—prostate cancer	6.8e-05	0.000268	CcSEcCtD
Niacin—Shock—Docetaxel—prostate cancer	6.8e-05	0.000268	CcSEcCtD
Niacin—Rash—Estradiol—prostate cancer	6.76e-05	0.000267	CcSEcCtD
Niacin—Dermatitis—Estradiol—prostate cancer	6.76e-05	0.000266	CcSEcCtD
Niacin—Tachycardia—Docetaxel—prostate cancer	6.74e-05	0.000266	CcSEcCtD
Niacin—Headache—Estradiol—prostate cancer	6.72e-05	0.000265	CcSEcCtD
Niacin—Skin disorder—Docetaxel—prostate cancer	6.71e-05	0.000264	CcSEcCtD
Niacin—Oedema—Capecitabine—prostate cancer	6.69e-05	0.000264	CcSEcCtD
Niacin—Angioedema—Prednisone—prostate cancer	6.67e-05	0.000263	CcSEcCtD
Niacin—Urticaria—Etoposide—prostate cancer	6.6e-05	0.00026	CcSEcCtD
Niacin—Haemoglobin—Epirubicin—prostate cancer	6.59e-05	0.00026	CcSEcCtD
Niacin—Jaundice—Doxorubicin—prostate cancer	6.59e-05	0.00026	CcSEcCtD
Niacin—Stomatitis—Doxorubicin—prostate cancer	6.59e-05	0.00026	CcSEcCtD
Niacin—Anorexia—Docetaxel—prostate cancer	6.58e-05	0.00026	CcSEcCtD
Niacin—Shock—Capecitabine—prostate cancer	6.58e-05	0.000259	CcSEcCtD
Niacin—Rhinitis—Epirubicin—prostate cancer	6.58e-05	0.000259	CcSEcCtD
Niacin—Abdominal pain—Etoposide—prostate cancer	6.57e-05	0.000259	CcSEcCtD
Niacin—Body temperature increased—Etoposide—prostate cancer	6.57e-05	0.000259	CcSEcCtD
Niacin—Vertigo—Prednisone—prostate cancer	6.56e-05	0.000259	CcSEcCtD
Niacin—Hepatitis—Epirubicin—prostate cancer	6.56e-05	0.000259	CcSEcCtD
Niacin—Haemorrhage—Epirubicin—prostate cancer	6.56e-05	0.000259	CcSEcCtD
Niacin—Syncope—Prednisone—prostate cancer	6.55e-05	0.000258	CcSEcCtD
Niacin—Tachycardia—Capecitabine—prostate cancer	6.53e-05	0.000257	CcSEcCtD
Niacin—Hypoaesthesia—Epirubicin—prostate cancer	6.53e-05	0.000257	CcSEcCtD
Niacin—Skin disorder—Capecitabine—prostate cancer	6.5e-05	0.000256	CcSEcCtD
Niacin—Sweating—Doxorubicin—prostate cancer	6.48e-05	0.000255	CcSEcCtD
Niacin—Hyperhidrosis—Capecitabine—prostate cancer	6.47e-05	0.000255	CcSEcCtD
Niacin—Oedema peripheral—Epirubicin—prostate cancer	6.46e-05	0.000255	CcSEcCtD
Niacin—Hypotension—Docetaxel—prostate cancer	6.46e-05	0.000254	CcSEcCtD
Niacin—Loss of consciousness—Prednisone—prostate cancer	6.42e-05	0.000253	CcSEcCtD
Niacin—Anorexia—Capecitabine—prostate cancer	6.38e-05	0.000251	CcSEcCtD
Niacin—Nausea—Estradiol—prostate cancer	6.37e-05	0.000251	CcSEcCtD
Niacin—Vomiting—Mitoxantrone—prostate cancer	6.35e-05	0.00025	CcSEcCtD
Niacin—Visual impairment—Epirubicin—prostate cancer	6.32e-05	0.000249	CcSEcCtD
Niacin—Rash—Mitoxantrone—prostate cancer	6.3e-05	0.000248	CcSEcCtD
Niacin—Dermatitis—Mitoxantrone—prostate cancer	6.3e-05	0.000248	CcSEcCtD
Niacin—Musculoskeletal discomfort—Docetaxel—prostate cancer	6.29e-05	0.000248	CcSEcCtD
Niacin—Headache—Mitoxantrone—prostate cancer	6.26e-05	0.000247	CcSEcCtD
Niacin—Hypotension—Capecitabine—prostate cancer	6.25e-05	0.000246	CcSEcCtD
Niacin—Insomnia—Docetaxel—prostate cancer	6.25e-05	0.000246	CcSEcCtD
Niacin—Arthralgia—Prednisone—prostate cancer	6.21e-05	0.000245	CcSEcCtD
Niacin—Myalgia—Prednisone—prostate cancer	6.21e-05	0.000245	CcSEcCtD
Niacin—Paraesthesia—Docetaxel—prostate cancer	6.2e-05	0.000244	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	6.17e-05	0.000243	CcSEcCtD
Niacin—Dyspnoea—Docetaxel—prostate cancer	6.16e-05	0.000243	CcSEcCtD
Niacin—Somnolence—Docetaxel—prostate cancer	6.14e-05	0.000242	CcSEcCtD
Niacin—Eye disorder—Epirubicin—prostate cancer	6.13e-05	0.000242	CcSEcCtD
Niacin—Hypersensitivity—Etoposide—prostate cancer	6.12e-05	0.000241	CcSEcCtD
Niacin—Tinnitus—Epirubicin—prostate cancer	6.11e-05	0.000241	CcSEcCtD
Niacin—Haemoglobin—Doxorubicin—prostate cancer	6.1e-05	0.00024	CcSEcCtD
Niacin—Musculoskeletal discomfort—Capecitabine—prostate cancer	6.09e-05	0.00024	CcSEcCtD
Niacin—Flushing—Epirubicin—prostate cancer	6.09e-05	0.00024	CcSEcCtD
Niacin—Rhinitis—Doxorubicin—prostate cancer	6.08e-05	0.00024	CcSEcCtD
Niacin—Dyspepsia—Docetaxel—prostate cancer	6.08e-05	0.00024	CcSEcCtD
Niacin—Haemorrhage—Doxorubicin—prostate cancer	6.07e-05	0.000239	CcSEcCtD
Niacin—Hepatitis—Doxorubicin—prostate cancer	6.07e-05	0.000239	CcSEcCtD
Niacin—Insomnia—Capecitabine—prostate cancer	6.05e-05	0.000238	CcSEcCtD
Niacin—Hypoaesthesia—Doxorubicin—prostate cancer	6.04e-05	0.000238	CcSEcCtD
Niacin—Paraesthesia—Capecitabine—prostate cancer	6.01e-05	0.000237	CcSEcCtD
Niacin—Decreased appetite—Docetaxel—prostate cancer	6.01e-05	0.000237	CcSEcCtD
Niacin—Oedema peripheral—Doxorubicin—prostate cancer	5.98e-05	0.000236	CcSEcCtD
Niacin—Gastrointestinal disorder—Docetaxel—prostate cancer	5.96e-05	0.000235	CcSEcCtD
Niacin—Asthenia—Etoposide—prostate cancer	5.96e-05	0.000235	CcSEcCtD
Niacin—Dyspnoea—Capecitabine—prostate cancer	5.96e-05	0.000235	CcSEcCtD
Niacin—Anaphylactic shock—Prednisone—prostate cancer	5.96e-05	0.000235	CcSEcCtD
Niacin—Oedema—Prednisone—prostate cancer	5.96e-05	0.000235	CcSEcCtD
Niacin—Angiopathy—Epirubicin—prostate cancer	5.95e-05	0.000235	CcSEcCtD
Niacin—Nausea—Mitoxantrone—prostate cancer	5.94e-05	0.000234	CcSEcCtD
Niacin—Pain—Docetaxel—prostate cancer	5.91e-05	0.000233	CcSEcCtD
Niacin—Dyspepsia—Capecitabine—prostate cancer	5.89e-05	0.000232	CcSEcCtD
Niacin—Chills—Epirubicin—prostate cancer	5.88e-05	0.000232	CcSEcCtD
Niacin—Pruritus—Etoposide—prostate cancer	5.88e-05	0.000232	CcSEcCtD
Niacin—Shock—Prednisone—prostate cancer	5.86e-05	0.000231	CcSEcCtD
Niacin—Arrhythmia—Epirubicin—prostate cancer	5.86e-05	0.000231	CcSEcCtD
Niacin—Visual impairment—Doxorubicin—prostate cancer	5.85e-05	0.000231	CcSEcCtD
Niacin—Tachycardia—Prednisone—prostate cancer	5.81e-05	0.000229	CcSEcCtD
Niacin—Decreased appetite—Capecitabine—prostate cancer	5.81e-05	0.000229	CcSEcCtD
Niacin—Alopecia—Epirubicin—prostate cancer	5.8e-05	0.000228	CcSEcCtD
Niacin—Skin disorder—Prednisone—prostate cancer	5.79e-05	0.000228	CcSEcCtD
Niacin—Gastrointestinal disorder—Capecitabine—prostate cancer	5.77e-05	0.000228	CcSEcCtD
Niacin—Hyperhidrosis—Prednisone—prostate cancer	5.76e-05	0.000227	CcSEcCtD
Niacin—Pain—Capecitabine—prostate cancer	5.72e-05	0.000225	CcSEcCtD
Niacin—Malnutrition—Epirubicin—prostate cancer	5.71e-05	0.000225	CcSEcCtD
Niacin—Erythema—Epirubicin—prostate cancer	5.71e-05	0.000225	CcSEcCtD
Niacin—Diarrhoea—Etoposide—prostate cancer	5.69e-05	0.000224	CcSEcCtD
Niacin—Anorexia—Prednisone—prostate cancer	5.68e-05	0.000224	CcSEcCtD
Niacin—Eye disorder—Doxorubicin—prostate cancer	5.67e-05	0.000224	CcSEcCtD
Niacin—Tinnitus—Doxorubicin—prostate cancer	5.66e-05	0.000223	CcSEcCtD
Niacin—Gastrointestinal pain—Docetaxel—prostate cancer	5.65e-05	0.000223	CcSEcCtD
Niacin—Flushing—Doxorubicin—prostate cancer	5.63e-05	0.000222	CcSEcCtD
Niacin—Flatulence—Epirubicin—prostate cancer	5.63e-05	0.000222	CcSEcCtD
Niacin—Tension—Epirubicin—prostate cancer	5.6e-05	0.000221	CcSEcCtD
Niacin—Nervousness—Epirubicin—prostate cancer	5.55e-05	0.000219	CcSEcCtD
Niacin—Angiopathy—Doxorubicin—prostate cancer	5.51e-05	0.000217	CcSEcCtD
Niacin—Dizziness—Etoposide—prostate cancer	5.5e-05	0.000217	CcSEcCtD
Niacin—Muscle spasms—Epirubicin—prostate cancer	5.49e-05	0.000216	CcSEcCtD
Niacin—Gastrointestinal pain—Capecitabine—prostate cancer	5.47e-05	0.000216	CcSEcCtD
Niacin—Abdominal pain—Docetaxel—prostate cancer	5.46e-05	0.000215	CcSEcCtD
Niacin—Body temperature increased—Docetaxel—prostate cancer	5.46e-05	0.000215	CcSEcCtD
Niacin—Chills—Doxorubicin—prostate cancer	5.44e-05	0.000215	CcSEcCtD
Niacin—Musculoskeletal discomfort—Prednisone—prostate cancer	5.43e-05	0.000214	CcSEcCtD
Niacin—Arrhythmia—Doxorubicin—prostate cancer	5.42e-05	0.000214	CcSEcCtD
Niacin—Insomnia—Prednisone—prostate cancer	5.39e-05	0.000212	CcSEcCtD
Niacin—Vision blurred—Epirubicin—prostate cancer	5.38e-05	0.000212	CcSEcCtD
Niacin—Alopecia—Doxorubicin—prostate cancer	5.36e-05	0.000211	CcSEcCtD
Niacin—Paraesthesia—Prednisone—prostate cancer	5.35e-05	0.000211	CcSEcCtD
Niacin—Urticaria—Capecitabine—prostate cancer	5.31e-05	0.000209	CcSEcCtD
Niacin—Abdominal pain—Capecitabine—prostate cancer	5.29e-05	0.000208	CcSEcCtD
Niacin—Body temperature increased—Capecitabine—prostate cancer	5.29e-05	0.000208	CcSEcCtD
Niacin—Vomiting—Etoposide—prostate cancer	5.29e-05	0.000208	CcSEcCtD
Niacin—Malnutrition—Doxorubicin—prostate cancer	5.28e-05	0.000208	CcSEcCtD
Niacin—Erythema—Doxorubicin—prostate cancer	5.28e-05	0.000208	CcSEcCtD
Niacin—Dyspepsia—Prednisone—prostate cancer	5.24e-05	0.000207	CcSEcCtD
Niacin—Rash—Etoposide—prostate cancer	5.24e-05	0.000207	CcSEcCtD
Niacin—Dermatitis—Etoposide—prostate cancer	5.24e-05	0.000206	CcSEcCtD
Niacin—Headache—Etoposide—prostate cancer	5.21e-05	0.000205	CcSEcCtD
Niacin—Flatulence—Doxorubicin—prostate cancer	5.21e-05	0.000205	CcSEcCtD
Niacin—Tension—Doxorubicin—prostate cancer	5.18e-05	0.000204	CcSEcCtD
Niacin—Decreased appetite—Prednisone—prostate cancer	5.18e-05	0.000204	CcSEcCtD
Niacin—Nervousness—Doxorubicin—prostate cancer	5.13e-05	0.000202	CcSEcCtD
Niacin—Vertigo—Epirubicin—prostate cancer	5.13e-05	0.000202	CcSEcCtD
Niacin—Syncope—Epirubicin—prostate cancer	5.12e-05	0.000202	CcSEcCtD
Niacin—Leukopenia—Epirubicin—prostate cancer	5.11e-05	0.000201	CcSEcCtD
Niacin—Hypersensitivity—Docetaxel—prostate cancer	5.09e-05	0.000201	CcSEcCtD
Niacin—Muscle spasms—Doxorubicin—prostate cancer	5.08e-05	0.0002	CcSEcCtD
Niacin—Palpitations—Epirubicin—prostate cancer	5.05e-05	0.000199	CcSEcCtD
Niacin—Loss of consciousness—Epirubicin—prostate cancer	5.02e-05	0.000198	CcSEcCtD
Niacin—Cough—Epirubicin—prostate cancer	4.98e-05	0.000196	CcSEcCtD
Niacin—Vision blurred—Doxorubicin—prostate cancer	4.98e-05	0.000196	CcSEcCtD
Niacin—Asthenia—Docetaxel—prostate cancer	4.96e-05	0.000195	CcSEcCtD
Niacin—Nausea—Etoposide—prostate cancer	4.94e-05	0.000195	CcSEcCtD
Niacin—Hypersensitivity—Capecitabine—prostate cancer	4.93e-05	0.000194	CcSEcCtD
Niacin—Pruritus—Docetaxel—prostate cancer	4.89e-05	0.000193	CcSEcCtD
Niacin—Gastrointestinal pain—Prednisone—prostate cancer	4.87e-05	0.000192	CcSEcCtD
Niacin—Arthralgia—Epirubicin—prostate cancer	4.86e-05	0.000192	CcSEcCtD
Niacin—Myalgia—Epirubicin—prostate cancer	4.86e-05	0.000192	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	4.83e-05	0.00019	CcSEcCtD
Niacin—Asthenia—Capecitabine—prostate cancer	4.8e-05	0.000189	CcSEcCtD
Niacin—Dry mouth—Epirubicin—prostate cancer	4.75e-05	0.000187	CcSEcCtD
Niacin—Vertigo—Doxorubicin—prostate cancer	4.75e-05	0.000187	CcSEcCtD
Niacin—Syncope—Doxorubicin—prostate cancer	4.74e-05	0.000187	CcSEcCtD
Niacin—Urticaria—Prednisone—prostate cancer	4.73e-05	0.000187	CcSEcCtD
Niacin—Pruritus—Capecitabine—prostate cancer	4.73e-05	0.000187	CcSEcCtD
Niacin—Leukopenia—Doxorubicin—prostate cancer	4.73e-05	0.000186	CcSEcCtD
Niacin—Diarrhoea—Docetaxel—prostate cancer	4.73e-05	0.000186	CcSEcCtD
Niacin—Abdominal pain—Prednisone—prostate cancer	4.71e-05	0.000186	CcSEcCtD
Niacin—Body temperature increased—Prednisone—prostate cancer	4.71e-05	0.000186	CcSEcCtD
Niacin—Palpitations—Doxorubicin—prostate cancer	4.67e-05	0.000184	CcSEcCtD
Niacin—Anaphylactic shock—Epirubicin—prostate cancer	4.66e-05	0.000184	CcSEcCtD
Niacin—Oedema—Epirubicin—prostate cancer	4.66e-05	0.000184	CcSEcCtD
Niacin—Loss of consciousness—Doxorubicin—prostate cancer	4.64e-05	0.000183	CcSEcCtD
Niacin—Cough—Doxorubicin—prostate cancer	4.61e-05	0.000182	CcSEcCtD
Niacin—Shock—Epirubicin—prostate cancer	4.58e-05	0.000181	CcSEcCtD
Niacin—Diarrhoea—Capecitabine—prostate cancer	4.58e-05	0.00018	CcSEcCtD
Niacin—Dizziness—Docetaxel—prostate cancer	4.57e-05	0.00018	CcSEcCtD
Niacin—Tachycardia—Epirubicin—prostate cancer	4.55e-05	0.000179	CcSEcCtD
Niacin—Skin disorder—Epirubicin—prostate cancer	4.53e-05	0.000178	CcSEcCtD
Niacin—Hyperhidrosis—Epirubicin—prostate cancer	4.5e-05	0.000178	CcSEcCtD
Niacin—Myalgia—Doxorubicin—prostate cancer	4.5e-05	0.000177	CcSEcCtD
Niacin—Arthralgia—Doxorubicin—prostate cancer	4.5e-05	0.000177	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	4.47e-05	0.000176	CcSEcCtD
Niacin—Anorexia—Epirubicin—prostate cancer	4.44e-05	0.000175	CcSEcCtD
Niacin—Dizziness—Capecitabine—prostate cancer	4.42e-05	0.000174	CcSEcCtD
Niacin—Dry mouth—Doxorubicin—prostate cancer	4.4e-05	0.000173	CcSEcCtD
Niacin—Vomiting—Docetaxel—prostate cancer	4.39e-05	0.000173	CcSEcCtD
Niacin—Hypersensitivity—Prednisone—prostate cancer	4.39e-05	0.000173	CcSEcCtD
Niacin—Rash—Docetaxel—prostate cancer	4.36e-05	0.000172	CcSEcCtD
Niacin—Hypotension—Epirubicin—prostate cancer	4.35e-05	0.000172	CcSEcCtD
Niacin—Dermatitis—Docetaxel—prostate cancer	4.35e-05	0.000172	CcSEcCtD
Niacin—Headache—Docetaxel—prostate cancer	4.33e-05	0.000171	CcSEcCtD
Niacin—Oedema—Doxorubicin—prostate cancer	4.31e-05	0.00017	CcSEcCtD
Niacin—Anaphylactic shock—Doxorubicin—prostate cancer	4.31e-05	0.00017	CcSEcCtD
Niacin—Asthenia—Prednisone—prostate cancer	4.27e-05	0.000168	CcSEcCtD
Niacin—Vomiting—Capecitabine—prostate cancer	4.25e-05	0.000168	CcSEcCtD
Niacin—Musculoskeletal discomfort—Epirubicin—prostate cancer	4.25e-05	0.000167	CcSEcCtD
Niacin—Shock—Doxorubicin—prostate cancer	4.24e-05	0.000167	CcSEcCtD
Niacin—Rash—Capecitabine—prostate cancer	4.22e-05	0.000166	CcSEcCtD
Niacin—Pruritus—Prednisone—prostate cancer	4.22e-05	0.000166	CcSEcCtD
Niacin—Insomnia—Epirubicin—prostate cancer	4.21e-05	0.000166	CcSEcCtD
Niacin—Dermatitis—Capecitabine—prostate cancer	4.21e-05	0.000166	CcSEcCtD
Niacin—Tachycardia—Doxorubicin—prostate cancer	4.21e-05	0.000166	CcSEcCtD
Niacin—Headache—Capecitabine—prostate cancer	4.19e-05	0.000165	CcSEcCtD
Niacin—Skin disorder—Doxorubicin—prostate cancer	4.19e-05	0.000165	CcSEcCtD
Niacin—Paraesthesia—Epirubicin—prostate cancer	4.18e-05	0.000165	CcSEcCtD
Niacin—Hyperhidrosis—Doxorubicin—prostate cancer	4.17e-05	0.000164	CcSEcCtD
Niacin—Dyspnoea—Epirubicin—prostate cancer	4.15e-05	0.000164	CcSEcCtD
Niacin—Somnolence—Epirubicin—prostate cancer	4.14e-05	0.000163	CcSEcCtD
Niacin—Anorexia—Doxorubicin—prostate cancer	4.11e-05	0.000162	CcSEcCtD
Niacin—Nausea—Docetaxel—prostate cancer	4.1e-05	0.000162	CcSEcCtD
Niacin—Dyspepsia—Epirubicin—prostate cancer	4.1e-05	0.000162	CcSEcCtD
Niacin—Diarrhoea—Prednisone—prostate cancer	4.08e-05	0.000161	CcSEcCtD
Niacin—Decreased appetite—Epirubicin—prostate cancer	4.05e-05	0.00016	CcSEcCtD
Niacin—Hypotension—Doxorubicin—prostate cancer	4.03e-05	0.000159	CcSEcCtD
Niacin—Gastrointestinal disorder—Epirubicin—prostate cancer	4.02e-05	0.000159	CcSEcCtD
Niacin—Pain—Epirubicin—prostate cancer	3.98e-05	0.000157	CcSEcCtD
Niacin—Nausea—Capecitabine—prostate cancer	3.97e-05	0.000157	CcSEcCtD
Niacin—Dizziness—Prednisone—prostate cancer	3.94e-05	0.000155	CcSEcCtD
Niacin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	3.93e-05	0.000155	CcSEcCtD
Niacin—Insomnia—Doxorubicin—prostate cancer	3.9e-05	0.000154	CcSEcCtD
Niacin—Paraesthesia—Doxorubicin—prostate cancer	3.87e-05	0.000153	CcSEcCtD
Niacin—Dyspnoea—Doxorubicin—prostate cancer	3.84e-05	0.000152	CcSEcCtD
Niacin—Somnolence—Doxorubicin—prostate cancer	3.83e-05	0.000151	CcSEcCtD
Niacin—Gastrointestinal pain—Epirubicin—prostate cancer	3.81e-05	0.00015	CcSEcCtD
Niacin—Dyspepsia—Doxorubicin—prostate cancer	3.8e-05	0.00015	CcSEcCtD
Niacin—Vomiting—Prednisone—prostate cancer	3.79e-05	0.000149	CcSEcCtD
Niacin—Rash—Prednisone—prostate cancer	3.76e-05	0.000148	CcSEcCtD
Niacin—Dermatitis—Prednisone—prostate cancer	3.75e-05	0.000148	CcSEcCtD
Niacin—Decreased appetite—Doxorubicin—prostate cancer	3.75e-05	0.000148	CcSEcCtD
Niacin—Headache—Prednisone—prostate cancer	3.73e-05	0.000147	CcSEcCtD
Niacin—Gastrointestinal disorder—Doxorubicin—prostate cancer	3.72e-05	0.000147	CcSEcCtD
Niacin—Urticaria—Epirubicin—prostate cancer	3.7e-05	0.000146	CcSEcCtD
Niacin—Pain—Doxorubicin—prostate cancer	3.69e-05	0.000145	CcSEcCtD
Niacin—Body temperature increased—Epirubicin—prostate cancer	3.68e-05	0.000145	CcSEcCtD
Niacin—Abdominal pain—Epirubicin—prostate cancer	3.68e-05	0.000145	CcSEcCtD
Niacin—Nausea—Prednisone—prostate cancer	3.54e-05	0.000139	CcSEcCtD
Niacin—Gastrointestinal pain—Doxorubicin—prostate cancer	3.53e-05	0.000139	CcSEcCtD
Niacin—Hypersensitivity—Epirubicin—prostate cancer	3.43e-05	0.000135	CcSEcCtD
Niacin—Urticaria—Doxorubicin—prostate cancer	3.43e-05	0.000135	CcSEcCtD
Niacin—Abdominal pain—Doxorubicin—prostate cancer	3.41e-05	0.000134	CcSEcCtD
Niacin—Body temperature increased—Doxorubicin—prostate cancer	3.41e-05	0.000134	CcSEcCtD
Niacin—Asthenia—Epirubicin—prostate cancer	3.34e-05	0.000132	CcSEcCtD
Niacin—Pruritus—Epirubicin—prostate cancer	3.3e-05	0.00013	CcSEcCtD
Niacin—Diarrhoea—Epirubicin—prostate cancer	3.19e-05	0.000126	CcSEcCtD
Niacin—Hypersensitivity—Doxorubicin—prostate cancer	3.18e-05	0.000125	CcSEcCtD
Niacin—Asthenia—Doxorubicin—prostate cancer	3.09e-05	0.000122	CcSEcCtD
Niacin—Dizziness—Epirubicin—prostate cancer	3.08e-05	0.000121	CcSEcCtD
Niacin—Pruritus—Doxorubicin—prostate cancer	3.05e-05	0.00012	CcSEcCtD
Niacin—Vomiting—Epirubicin—prostate cancer	2.96e-05	0.000117	CcSEcCtD
Niacin—Diarrhoea—Doxorubicin—prostate cancer	2.95e-05	0.000116	CcSEcCtD
Niacin—Rash—Epirubicin—prostate cancer	2.94e-05	0.000116	CcSEcCtD
Niacin—Dermatitis—Epirubicin—prostate cancer	2.94e-05	0.000116	CcSEcCtD
Niacin—Headache—Epirubicin—prostate cancer	2.92e-05	0.000115	CcSEcCtD
Niacin—Dizziness—Doxorubicin—prostate cancer	2.85e-05	0.000112	CcSEcCtD
Niacin—Nausea—Epirubicin—prostate cancer	2.77e-05	0.000109	CcSEcCtD
Niacin—Vomiting—Doxorubicin—prostate cancer	2.74e-05	0.000108	CcSEcCtD
Niacin—Rash—Doxorubicin—prostate cancer	2.72e-05	0.000107	CcSEcCtD
Niacin—Dermatitis—Doxorubicin—prostate cancer	2.72e-05	0.000107	CcSEcCtD
Niacin—Headache—Doxorubicin—prostate cancer	2.7e-05	0.000106	CcSEcCtD
Niacin—Nausea—Doxorubicin—prostate cancer	2.56e-05	0.000101	CcSEcCtD
Niacin—SLC16A3—Metabolism—ERCC2—prostate cancer	1.76e-05	8.73e-05	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—KRAS—prostate cancer	1.74e-05	8.65e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—ERBB2—prostate cancer	1.74e-05	8.62e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—CREBBP—prostate cancer	1.72e-05	8.51e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NCOA3—prostate cancer	1.72e-05	8.51e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CB—prostate cancer	1.71e-05	8.5e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—JAK2—prostate cancer	1.71e-05	8.49e-05	CbGpPWpGaD
Niacin—QPRT—Disease—PIK3CA—prostate cancer	1.71e-05	8.47e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IGF1—prostate cancer	1.69e-05	8.41e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—PIK3CA—prostate cancer	1.68e-05	8.32e-05	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.67e-05	8.29e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MDM2—prostate cancer	1.67e-05	8.29e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—MTHFR—prostate cancer	1.65e-05	8.21e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CXCL8—prostate cancer	1.65e-05	8.17e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ERBB2—prostate cancer	1.65e-05	8.17e-05	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—GSTM1—prostate cancer	1.65e-05	8.17e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—HPGDS—prostate cancer	1.64e-05	8.12e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CD—prostate cancer	1.63e-05	8.07e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP2C19—prostate cancer	1.63e-05	8.06e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CB—prostate cancer	1.63e-05	8.06e-05	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—GSTM1—prostate cancer	1.62e-05	8.05e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PPARA—prostate cancer	1.62e-05	8.05e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—SERPINE1—prostate cancer	1.61e-05	7.98e-05	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—PPARA—prostate cancer	1.61e-05	7.98e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CDKN1B—prostate cancer	1.61e-05	7.98e-05	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—PIK3CA—prostate cancer	1.6e-05	7.94e-05	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—AKT1—prostate cancer	1.59e-05	7.89e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ACHE—prostate cancer	1.59e-05	7.87e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTT1—prostate cancer	1.59e-05	7.87e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CASP3—prostate cancer	1.58e-05	7.82e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL2—prostate cancer	1.57e-05	7.81e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP2A6—prostate cancer	1.57e-05	7.78e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—IL6—prostate cancer	1.57e-05	7.77e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CXCL8—prostate cancer	1.56e-05	7.75e-05	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—CYP1A1—prostate cancer	1.56e-05	7.74e-05	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TP53—prostate cancer	1.55e-05	7.68e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HAO1—prostate cancer	1.54e-05	7.64e-05	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CYP1A1—prostate cancer	1.54e-05	7.64e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—NOS3—prostate cancer	1.54e-05	7.62e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CCND1—prostate cancer	1.53e-05	7.61e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—AKR1C3—prostate cancer	1.53e-05	7.57e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CAV1—prostate cancer	1.53e-05	7.57e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CDKN1B—prostate cancer	1.53e-05	7.57e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CTNNB1—prostate cancer	1.52e-05	7.54e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PRKACB—prostate cancer	1.52e-05	7.53e-05	CbGpPWpGaD
Niacin—QPRT—Disease—IL6—prostate cancer	1.51e-05	7.5e-05	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—AKT1—prostate cancer	1.51e-05	7.48e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP17A1—prostate cancer	1.5e-05	7.45e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CASP3—prostate cancer	1.49e-05	7.42e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—JAK2—prostate cancer	1.49e-05	7.41e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL2—prostate cancer	1.49e-05	7.4e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MMP9—prostate cancer	1.49e-05	7.39e-05	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.49e-05	7.37e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—IL6—prostate cancer	1.49e-05	7.37e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CDKN1A—prostate cancer	1.48e-05	7.37e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PTEN—prostate cancer	1.48e-05	7.35e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCND1—prostate cancer	1.46e-05	7.22e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—AKT1—prostate cancer	1.45e-05	7.17e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CTNNB1—prostate cancer	1.44e-05	7.15e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NCOA2—prostate cancer	1.43e-05	7.1e-05	CbGpPWpGaD
Niacin—QPRT—Metabolism—PIK3CA—prostate cancer	1.43e-05	7.09e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CB—prostate cancer	1.42e-05	7.04e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—EP300—prostate cancer	1.41e-05	7.01e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MMP9—prostate cancer	1.41e-05	7.01e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CDKN1A—prostate cancer	1.41e-05	6.98e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PTEN—prostate cancer	1.4e-05	6.97e-05	CbGpPWpGaD
Niacin—QPRT—Disease—AKT1—prostate cancer	1.39e-05	6.92e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CG—prostate cancer	1.39e-05	6.89e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SRC—prostate cancer	1.37e-05	6.81e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—AKT1—prostate cancer	1.37e-05	6.8e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SLC5A5—prostate cancer	1.37e-05	6.77e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EP300—prostate cancer	1.34e-05	6.64e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—VEGFA—prostate cancer	1.34e-05	6.64e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP2E1—prostate cancer	1.33e-05	6.62e-05	CbGpPWpGaD
Niacin—NNMT—Metabolism—PIK3CA—prostate cancer	1.33e-05	6.59e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—STAT3—prostate cancer	1.32e-05	6.57e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NQO1—prostate cancer	1.32e-05	6.54e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—INS—prostate cancer	1.32e-05	6.53e-05	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—AKT1—prostate cancer	1.31e-05	6.49e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IL2—prostate cancer	1.3e-05	6.46e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SRC—prostate cancer	1.3e-05	6.46e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—TH—prostate cancer	1.3e-05	6.45e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CREBBP—prostate cancer	1.29e-05	6.39e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP3A4—prostate cancer	1.29e-05	6.38e-05	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.28e-05	6.34e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—VEGFA—prostate cancer	1.27e-05	6.29e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP1B1—prostate cancer	1.26e-05	6.27e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—STAT3—prostate cancer	1.26e-05	6.23e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CSAD—prostate cancer	1.26e-05	6.23e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GRHL1—prostate cancer	1.26e-05	6.23e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PSAT1—prostate cancer	1.26e-05	6.23e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ADI1—prostate cancer	1.26e-05	6.23e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—TST—prostate cancer	1.26e-05	6.23e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CBR1—prostate cancer	1.26e-05	6.23e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MYC—prostate cancer	1.23e-05	6.11e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TGFB1—prostate cancer	1.23e-05	6.09e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GGT1—prostate cancer	1.22e-05	6.07e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CD—prostate cancer	1.22e-05	6.06e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NCOA1—prostate cancer	1.21e-05	5.98e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—EGFR—prostate cancer	1.2e-05	5.97e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP19A1—prostate cancer	1.19e-05	5.9e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—EP300—prostate cancer	1.17e-05	5.8e-05	CbGpPWpGaD
Niacin—QPRT—Metabolism—AKT1—prostate cancer	1.17e-05	5.79e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—UGT2B17—prostate cancer	1.17e-05	5.79e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CKMT2—prostate cancer	1.17e-05	5.79e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—UGT2B15—prostate cancer	1.17e-05	5.79e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GRHPR—prostate cancer	1.17e-05	5.79e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MYC—prostate cancer	1.17e-05	5.79e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TGFB1—prostate cancer	1.16e-05	5.78e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—NOS3—prostate cancer	1.15e-05	5.72e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—RXRA—prostate cancer	1.15e-05	5.69e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EGFR—prostate cancer	1.14e-05	5.66e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—KRAS—prostate cancer	1.14e-05	5.64e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—SRC—prostate cancer	1.14e-05	5.64e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—VEGFA—prostate cancer	1.11e-05	5.49e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—COMT—prostate cancer	1.11e-05	5.48e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTP1—prostate cancer	1.1e-05	5.46e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NAGLU—prostate cancer	1.1e-05	5.44e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—RFK—prostate cancer	1.1e-05	5.44e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTM3—prostate cancer	1.1e-05	5.44e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SULT2B1—prostate cancer	1.1e-05	5.44e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AOX1—prostate cancer	1.1e-05	5.44e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PGAM2—prostate cancer	1.1e-05	5.44e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—MBTPS1—prostate cancer	1.1e-05	5.44e-05	CbGpPWpGaD
Niacin—NNMT—Metabolism—AKT1—prostate cancer	1.09e-05	5.39e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ITPR1—prostate cancer	1.08e-05	5.37e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—KRAS—prostate cancer	1.08e-05	5.35e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CB—prostate cancer	1.06e-05	5.28e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTGS2—prostate cancer	1.06e-05	5.23e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CA—prostate cancer	1.05e-05	5.18e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NAT1—prostate cancer	1.04e-05	5.16e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP3A43—prostate cancer	1.04e-05	5.16e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AMACR—prostate cancer	1.04e-05	5.16e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—DEGS1—prostate cancer	1.04e-05	5.16e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SRD5A2—prostate cancer	1.04e-05	5.16e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—TYMS—prostate cancer	1.02e-05	5.07e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TGFB1—prostate cancer	1.02e-05	5.04e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TP53—prostate cancer	1.01e-05	5.02e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTM1—prostate cancer	1.01e-05	5.01e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HSD17B1—prostate cancer	9.93e-06	4.92e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—LPL—prostate cancer	9.92e-06	4.92e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CA—prostate cancer	9.91e-06	4.91e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TP53—prostate cancer	9.58e-06	4.75e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP1A1—prostate cancer	9.58e-06	4.75e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ERCC2—prostate cancer	9.5e-06	4.71e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—KRAS—prostate cancer	9.41e-06	4.67e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL6—prostate cancer	9.25e-06	4.59e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTEN—prostate cancer	9.2e-06	4.56e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—MTHFR—prostate cancer	8.93e-06	4.43e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—B4GALT4—prostate cancer	8.85e-06	4.39e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HPGD—prostate cancer	8.85e-06	4.39e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—EP300—prostate cancer	8.78e-06	4.35e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL6—prostate cancer	8.77e-06	4.35e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PPARA—prostate cancer	8.76e-06	4.35e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CA—prostate cancer	8.65e-06	4.29e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—AKT1—prostate cancer	8.54e-06	4.24e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TP53—prostate cancer	8.37e-06	4.15e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—TNFRSF21—prostate cancer	8.32e-06	4.13e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CAV1—prostate cancer	8.24e-06	4.09e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—AKT1—prostate cancer	8.09e-06	4.01e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP7B1—prostate cancer	8.09e-06	4.01e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—MTAP—prostate cancer	8.09e-06	4.01e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SULT1E1—prostate cancer	7.89e-06	3.91e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SRD5A1—prostate cancer	7.89e-06	3.91e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HSD17B3—prostate cancer	7.52e-06	3.73e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ACSL4—prostate cancer	7.52e-06	3.73e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CG—prostate cancer	7.51e-06	3.72e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ARG2—prostate cancer	7.21e-06	3.58e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PHGDH—prostate cancer	7.21e-06	3.58e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—UMPS—prostate cancer	7.21e-06	3.58e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—INS—prostate cancer	7.1e-06	3.52e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—LDHB—prostate cancer	7.07e-06	3.51e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—AKT1—prostate cancer	7.06e-06	3.5e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CREBBP—prostate cancer	6.96e-06	3.45e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP3A5—prostate cancer	6.94e-06	3.44e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTA3—prostate cancer	6.7e-06	3.33e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—UCP3—prostate cancer	6.7e-06	3.33e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—TCN2—prostate cancer	6.7e-06	3.33e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PDHA1—prostate cancer	6.7e-06	3.33e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CD—prostate cancer	6.6e-06	3.27e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CA—prostate cancer	6.49e-06	3.22e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HSD3B1—prostate cancer	6.4e-06	3.17e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC22A3—prostate cancer	6.4e-06	3.17e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NOS3—prostate cancer	6.23e-06	3.09e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTA4—prostate cancer	6.13e-06	3.04e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—TBXAS1—prostate cancer	6.13e-06	3.04e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTA2—prostate cancer	5.98e-06	2.96e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ABCG5—prostate cancer	5.9e-06	2.93e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SULT1A1—prostate cancer	5.9e-06	2.93e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTA1—prostate cancer	5.77e-06	2.86e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CB—prostate cancer	5.75e-06	2.85e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NAT2—prostate cancer	5.7e-06	2.83e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HSD3B2—prostate cancer	5.7e-06	2.83e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTO1—prostate cancer	5.7e-06	2.83e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTGS2—prostate cancer	5.7e-06	2.83e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PLCB2—prostate cancer	5.47e-06	2.71e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—LRP2—prostate cancer	5.47e-06	2.71e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP2C18—prostate cancer	5.47e-06	2.71e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—P4HB—prostate cancer	5.36e-06	2.66e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—AKT1—prostate cancer	5.3e-06	2.63e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC22A1—prostate cancer	5.21e-06	2.59e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SULT2A1—prostate cancer	5.08e-06	2.52e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—MED12—prostate cancer	5e-06	2.48e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTEN—prostate cancer	4.97e-06	2.47e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GNG5—prostate cancer	4.96e-06	2.46e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NCOA3—prostate cancer	4.78e-06	2.37e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—EP300—prostate cancer	4.74e-06	2.35e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HPGDS—prostate cancer	4.56e-06	2.26e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP2C19—prostate cancer	4.53e-06	2.25e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTT1—prostate cancer	4.42e-06	2.19e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ACHE—prostate cancer	4.42e-06	2.19e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP2A6—prostate cancer	4.37e-06	2.17e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AKR1C3—prostate cancer	4.25e-06	2.11e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PRKACB—prostate cancer	4.23e-06	2.1e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP17A1—prostate cancer	4.18e-06	2.08e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NCOA2—prostate cancer	3.99e-06	1.98e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC5A5—prostate cancer	3.8e-06	1.89e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP2E1—prostate cancer	3.72e-06	1.84e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NQO1—prostate cancer	3.67e-06	1.82e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—TH—prostate cancer	3.62e-06	1.8e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP3A4—prostate cancer	3.58e-06	1.78e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP1B1—prostate cancer	3.52e-06	1.75e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CA—prostate cancer	3.51e-06	1.74e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GGT1—prostate cancer	3.41e-06	1.69e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NCOA1—prostate cancer	3.36e-06	1.67e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP19A1—prostate cancer	3.31e-06	1.64e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—RXRA—prostate cancer	3.2e-06	1.59e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—COMT—prostate cancer	3.08e-06	1.53e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTP1—prostate cancer	3.06e-06	1.52e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ITPR1—prostate cancer	3.01e-06	1.5e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—AKT1—prostate cancer	2.86e-06	1.42e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—TYMS—prostate cancer	2.85e-06	1.41e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTM1—prostate cancer	2.82e-06	1.4e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—LPL—prostate cancer	2.76e-06	1.37e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP1A1—prostate cancer	2.67e-06	1.32e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ERCC2—prostate cancer	2.65e-06	1.31e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—MTHFR—prostate cancer	2.49e-06	1.23e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PPARA—prostate cancer	2.44e-06	1.21e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CAV1—prostate cancer	2.3e-06	1.14e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.09e-06	1.04e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—INS—prostate cancer	1.98e-06	9.82e-06	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CREBBP—prostate cancer	1.94e-06	9.62e-06	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.84e-06	9.12e-06	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NOS3—prostate cancer	1.74e-06	8.61e-06	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.6e-06	7.95e-06	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTGS2—prostate cancer	1.59e-06	7.87e-06	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTEN—prostate cancer	1.38e-06	6.87e-06	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—EP300—prostate cancer	1.32e-06	6.55e-06	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CA—prostate cancer	9.77e-07	4.84e-06	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AKT1—prostate cancer	7.98e-07	3.96e-06	CbGpPWpGaD
